These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7217264)

  • 21. Determination of maprotiline in plasma by high-performance liquid chromatography with chemiluminescence detection.
    Ishida J; Horike N; Yamaguchi M
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):390-6. PubMed ID: 7581917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of the antidepressants maprotiline and amoxapine, and their metabolites, in plasma by liquid chromatography.
    Wong SH; Waugh SW
    Clin Chem; 1983 Feb; 29(2):314-8. PubMed ID: 6821936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics.
    Dieterle W; Faigle JW; Imhof P; Sulc M; Wagner J
    Xenobiotica; 1984 Apr; 14(4):303-10. PubMed ID: 6464500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Simultaneous monitoring of maprotiline and some benzodiazepines in human plasma by gas chromatography].
    Quaglio MP; Bellini AM
    Farmaco Prat; 1984 Dec; 39(12):431-7. PubMed ID: 6152224
    [No Abstract]   [Full Text] [Related]  

  • 25. Liquid-chromatographic determination of amitryptyline and its metabolites in serum, with adsorption onto glass minimized.
    Edelbroek PM; de Haas EJ; de Wolff FA
    Clin Chem; 1982 Oct; 28(10):2143-8. PubMed ID: 7127744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in slow evoked potentials in depressed patients treated with amitriptyline and oxaprotiline].
    Giedke H; Heimann H; Rein W
    Rev Electroencephalogr Neurophysiol Clin; 1987 Sep; 17(3):279-87. PubMed ID: 3685573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1984 Apr; 14(4):311-9. PubMed ID: 6464501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of maprotiline and its desmethylated metabolite serum concentrations in outpatients and inpatients.
    Kurata K; Kido H; Hasegawa M; Inoue M; Yamaguchi N
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):255-60. PubMed ID: 3437613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gas chromatography-mass spectrometry of maprotiline in serum.
    Skrinska V; Ohman J; Wellstead C; Hahn K
    Clin Chem; 1984 Jul; 30(7):1276-7. PubMed ID: 6733926
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative speed of onset of the antidepressant effect of maprotiline.
    Silverstone T
    Clin Ther; 1981; 3(5):374-81. PubMed ID: 7471133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma protein binding of maprotiline in geriatric patients--influence of alpha1-acid glycoprotein [proceedings].
    Braithwaite RA; Heard R; Snape A
    Br J Clin Pharmacol; 1978 Nov; 6(5):448P-449P. PubMed ID: 728299
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dog.
    Dieterle W; Faigle JW; Kriemler HP; Winkler T
    Xenobiotica; 1986 Aug; 16(8):743-52. PubMed ID: 3765655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
    Lôo H; Benkelfat C; Poirier MF; Vanelle JM; Olié JP; Dennis T; Scatton B
    Neuropsychobiology; 1986; 15(2):62-7. PubMed ID: 3762900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of maprotiline (Ludiomil) and amitriptyline (2).
    Mindham BA
    J Int Med Res; 1977; 5 Suppl 4():25-33. PubMed ID: 338399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of maprotiline and amitriptyline in the treatment of depression in general practice.
    Silverstone JT; Carne HJ; Dell A; Franklin CJ; Singer R; Swirsky SN; Forrest WA
    Practitioner; 1977 Feb; 218(1304):279-82. PubMed ID: 320594
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison of maprotiline (Ludiomil) and amitriptyline (1).
    Dell AJ
    J Int Med Res; 1977; 5 Suppl 4():22-4. PubMed ID: 338398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.
    Fischbach R
    Arzneimittelforschung; 1979; 29(2):352-5. PubMed ID: 36112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.